Clinical Trials Directory

Trials / Completed

CompletedNCT01429285

Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain

Safety and Efficacy of Intravenous Hydromorphone Using Incremental Doses of 0.5 mg in Elderly ED Patients With Acute Severe Pain

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
350 (actual)
Sponsor
Montefiore Medical Center · Academic / Other
Sex
All
Age
65 Years – 120 Years
Healthy volunteers
Accepted

Summary

The hydromorphone protocol is more effective than usual care in Emergency Department (ED) patients age 65 years and older in terms of proportion who choose to forgo additional pain medication within 60 minutes post-baseline in the two groups.

Conditions

Interventions

TypeNameDescription
DRUGHydromorphone0.5 mg IV hydromorphone followed by an optional 0.5 mg IV dose
DRUGUsual careAttending administers any IV opioid in any dose he chooses

Timeline

Start date
2009-07-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2011-09-07
Last updated
2018-05-18
Results posted
2018-04-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01429285. Inclusion in this directory is not an endorsement.